X-119872026-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_004541.4(NDUFA1):c.102+13C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000308 in 1,202,419 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00015 ( 0 hom., 2 hem., cov: 24)
Exomes 𝑓: 0.000018 ( 0 hom. 5 hem. )
Consequence
NDUFA1
NM_004541.4 intron
NM_004541.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0540
Genes affected
NDUFA1 (HGNC:7683): (NADH:ubiquinone oxidoreductase subunit A1) The human NDUFA1 gene codes for an essential component of complex I of the respiratory chain, which transfers electrons from NADH to ubiquinone. It has been noted that the N-terminal hydrophobic domain has the potential to be folded into an alpha-helix spanning the inner mitochondrial membrane with a C-terminal hydrophilic domain interacting with globular subunits of complex I. The highly conserved two-domain structure suggests that this feature is critical for the protein function and might act as an anchor for the NADH:ubiquinone oxidoreductase complex at the inner mitochondrial membrane. However, the NDUFA1 peptide is one of about 31 components of the "hydrophobic protein" (HP) fraction of complex I which is involved in proton translocation. Thus the NDUFA1 peptide may also participate in that function. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant X-119872026-C-T is Benign according to our data. Variant chrX-119872026-C-T is described in ClinVar as [Benign]. Clinvar id is 1988194.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NDUFA1 | NM_004541.4 | c.102+13C>T | intron_variant | ENST00000371437.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NDUFA1 | ENST00000371437.5 | c.102+13C>T | intron_variant | 1 | NM_004541.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000150 AC: 17AN: 112961Hom.: 0 Cov.: 24 AF XY: 0.0000570 AC XY: 2AN XY: 35105
GnomAD3 genomes
AF:
AC:
17
AN:
112961
Hom.:
Cov.:
24
AF XY:
AC XY:
2
AN XY:
35105
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000219 AC: 4AN: 182686Hom.: 0 AF XY: 0.0000297 AC XY: 2AN XY: 67400
GnomAD3 exomes
AF:
AC:
4
AN:
182686
Hom.:
AF XY:
AC XY:
2
AN XY:
67400
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000184 AC: 20AN: 1089405Hom.: 0 Cov.: 30 AF XY: 0.0000141 AC XY: 5AN XY: 355227
GnomAD4 exome
AF:
AC:
20
AN:
1089405
Hom.:
Cov.:
30
AF XY:
AC XY:
5
AN XY:
355227
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000150 AC: 17AN: 113014Hom.: 0 Cov.: 24 AF XY: 0.0000569 AC XY: 2AN XY: 35168
GnomAD4 genome
AF:
AC:
17
AN:
113014
Hom.:
Cov.:
24
AF XY:
AC XY:
2
AN XY:
35168
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Sep 06, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at